George Kafatos

Amgen (United States) — United States

Medicine · Health Sciences

29h-index3.6kcitations95works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(27), Lung Cancer Treatments and Mutations(10), Gastric Cancer Management and Outcomes(10), Viral gastroenteritis research and epidemiology(10), Cancer Genomics and Diagnostics(9)

Publications95 total

RWD118 Leveraging Large-Language Models for Medical Code List Creation: An Example Using the Charlson Comorbidity Index
Value in Health·2025
Comparison of Epidemiological Estimates for 19 Cancer Types Using Electronic Health Record Databases in England: An Analysis of CPRD Aurum and CPRD GOLD Databases with Linked Hospital Episode Statistics and Cancer Registry Data
Clinical Epidemiology·2025Open Access
RWD100 Improving Access to German Health Claims Data Through Synthetic Data Generation: Findings and Achievements of a Holistic Evaluation
Value in Health·2025
Validation of the transformed clinical practice research datalink (CPRD) GOLD and aurum data into the OMOP common data model
Health Informatics Journal·2025Open Access
Leveraging Synthetic Data to Facilitate Research: A Collaborative Model for Analyzing Sensitive National Cancer Registry Data in England
Therapeutic Innovation & Regulatory Science·2025· 1 citedOpen Access
Validation of Clinical Practice Research Datalink (<scp>CPRD</scp>) Aurum Mother‐Baby Link
Pharmacoepidemiology and Drug Safety·2025· 1 citedOpen Access
A Curve-Fitting Approach for Generating Long-Term Projections of COVID-19 Mortality
Disaster Medicine and Public Health Preparedness·2025Open Access
RWD196 Improving Access to German Health Claims Data Through Synthetic Data Generation: A Methodological Comparison of Different Approaches
Value in Health·2024Open Access
Presence of Breast Cancer Information Recorded in United Kingdom Primary Care Databases: Comparison of CPRD Aurum and CPRD GOLD (Companion Paper 1)
Clinical Epidemiology·2023· 8 citedOpen Access
Correctness and Completeness of Breast Cancer Diagnoses Recorded in UK CPRD Aurum and CPRD GOLD Databases: Comparison to Hospital Episode Statistics and Cancer Registry (Companion Paper 2)
Clinical Epidemiology·2023· 6 citedOpen Access
Use of the CPRD Aurum Database: Insights Gained from New Data Quality Assessments
Clinical Epidemiology·2023· 18 citedOpen Access
Comparison of Rheumatoid Arthritis Information Recorded in UK CPRD Aurum and CPRD GOLD Databases (Companion Paper 3)
Clinical Epidemiology·2023· 2 citedOpen Access
Utilization patterns and factors associated with persistence of new users of anti-osteoporosis treatment in Denmark: a population-based cohort study
Archives of Osteoporosis·2023· 12 citedOpen Access
The Alignment of Real-World Evidence and Digital Health: Realising the Opportunity
Therapeutic Innovation & Regulatory Science·2021· 24 citedOpen Access
Biomarker Testing and Mutation Prevalence in Metastatic Colorectal Cancer Patients in Five European Countries Using a Large Oncology Database
Future Oncology·2021· 9 citedOpen Access
Impact of Biomarkers and Primary Tumor Location on the Metastatic Colorectal Cancer First-Line Treatment Landscape in Five European Countries
Future Oncology·2021· 4 citedOpen Access
Real‐world reproducibility study characterizing patients newly diagnosed with multiple myeloma using Clinical Practice Research Datalink, a <scp>UK</scp>‐based electronic health records database
Pharmacoepidemiology and Drug Safety·2020· 7 citedOpen Access
The Healthcare Professionals’ Perspective on Impact and Actions Taken Following Severe Infusion Reaction Events in Oncology Centers in Europe
Drugs - Real World Outcomes·2020· 2 citedOpen Access
Management of EGFR Inhibitor-induced Skin Toxicity and Factors Impacting Patients’ Adherence to Skin Toxicity Treatment: Health Care Provider and Patient Surveys in European Oncology Centers
Clinical Colorectal Cancer·2020· 17 cited
Evolution of <i>RAS</i> Testing Over Time: Factors Influencing Mutation Rates in Metastatic Colorectal Cancer Patients
Colorectal Cancer·2020· 4 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Nick Andrews(16), Richard Pebody(10), Fernando de Ory(8), Joël Mossong(8), Anthony Nardone(8), Irja Davidkin(7), R. Vranckx(6), Dani Cohen(5), L. Jones(5), F Schneider(5), Elizabeth Miller(5), Cleo Anastassopoulou(5), Cristina Bárbara(5), Algirdas Griškevičius(5), Louise Hesketh(5), J. Han van Krieken(4), D O’Flanagan(4), Katarina Prosenc(4), Athanasios Tsakris(4), P.A.C. Maple(4)